Bin Dong

This publication record appears to combine at least two distinct research threads under the name Bin Dong: one involving optical and spectroscopic imaging methods (such as stimulated Raman scattering microscopy) to study cell processes like programmed cell death, and another involving large multi-site clinical trials of a drug called tulisokibart for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. Prospective students should note the data likely reflects contributions from multiple people sharing this name, spanning basic laboratory science and clinical trial reporting.

Publication output has grown sharply in recent years, rising from single-digit counts through the late 2010s and early 2020s to 31 outputs in 2025, though this recent surge and topical breadth may reflect merged records from multiple researchers.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026